sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1397.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 28-Aug-2017
ESC Congress 2017
Married patients with heart disease have better survival rates
Marriage is a vital factor affecting the survival of patients who have had a heart attack, as well as the survival of patients with the most important risk factors, according to research presented today at ESC Congress.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
New England Journal of Medicine
Drug cuts cardiovascular disease and lung cancer risk by reducing inflammation (CANTOS)
The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by reducing inflammation, according to late-breaking results from the CANTOS trial presented today in a Hot Line -- LBT Session at ESC Congress1 and published in the NEJM.
Novartis

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Catheter ablation improves outcomes in patients with heart failure and AF (CASTLE-A)
Catheter ablation improves outcomes for patients with left ventricular dysfunction and atrial fibrillation, according to late-breaking results from the CASTLE-AF trial presented today in a Hot Line -- LBCT Session at ESC Congress.1 Patients who received catheter ablation of atrial fibrillation had lower mortality and less hospitalisation for worsening heart failure compared to those receiving conventional drug treatment.
Biotronik GmbH

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
New England Journal of Medicine
Rivaroxaban plus aspirin improves outcomes in stable cardiovascular disease (COMPASS)
Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in the NEJM.
Bayer AG

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Rivaroxaban plus aspirin reduces adverse events (COMPASS)
Rivaroxaban plus aspirin reduces major adverse cardiovascular and limb events by nearly one-third in patients with peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line -- LBCT Session at ESC Congress.
Bayer AG

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Risk factor driven upstream AF therapy improves sinus rhythm (RACE 3)
Risk factor driven upstream rhythm control is effective, feasible and safe in improving maintenance of sinus rhythm in patients with early short lasting atrial fibrillation (AF) and heart failure, according to late-breaking results from the RACE 3 trial presented today in a Hot Line - LBCT Session at ESC Congress.1 The novel therapy included meticulous treatment of risk factors and change of lifestyle and was superior to conventional guideline recommended rhythm control.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Automatic external defibrillators save lives in amateur sports and fitness centers
Automatic external defibrillators (AEDs) save lives in amateur sports and fitness centers, according to research presented at ESC Congress today. The 18-year study found that survival from cardiac arrest reached 93 percent in centers equipped with an AED.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Higher coffee consumption associated with lower risk of death
Higher coffee consumption is associated with a lower risk of death, according to research presented today at ESC Congress.1 The observational study in nearly 20 000 participants suggests that coffee can be part of a healthy diet in healthy people.
Instituto de Salud Carlos III, CIBER, Regional Government of Navarra

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
Study confirms safety of rapid algorithm to rule-out and rule-in myocardial infarction
The safety and efficacy of a rapid algorithm to rule-out and rule-in myocardial infarction has been confirmed in a study presented at ESC Congress today.
Swiss National Science Foundation, Swiss Heart Foundation, KTI, European Union, Stiftung für kardiovaskuläre Forschung Basel, Abbott, Beckman Coulter, Biomerieux, Brahms

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
PCSK9 is a co-activator of platelet function beyond its role in cholesterol homeostasis
PCSK9 is a co-activator of platelet function beyond its role in cholesterol homeostasis, according to research presented at ESC Congress today. The findings suggest that PCSK9 inhibitors, a new class of cholesterol-lowering treatments, may also reduce thrombosis by interfering with platelet activation.
2016 ASPIRE Cardiovascular Competitive Research Grant, Pfizer

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 27-Aug-2017
ESC Congress 2017
High salt intake associated with doubled risk of heart failure
High salt intake is associated with a doubled risk of heart failure, according to a 12-year study in more than 4 000 people presented today at ESC Congress.
National Institute of Health and Welfare (formerly National Public Health Institute)

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC Guidelines on ST-segment elevation myocardial infarction published today
European Society of Cardiology (ESC) Guidelines on the management of acute myocardial infarction in patients with ST-segment elevation are published online today in European Heart Journal,1 and on the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC focused update on dual antiplatelet therapy in coronary artery disease published today
The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal,1 and on the ESC website.2 The document was developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases published today
European Society of Cardiology (ESC) Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, developed in collaboration with the European Society for Vascular Surgery (ESVS), are published online today in European Heart Journal,1 European Journal of Vascular and Endovascular Surgery, and the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
European Heart Journal
ESC/EACTS Guidelines for the management of valvular heart disease published today
European Society of Cardiology (ESC) / European Association for Cardio-Thoracic Surgery (EACTS) Guidelines for the management of valvular heart disease are published online today in European Heart Journal1 and on the ESC website.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
Underweight associated with highest mortality and costs after cardiac catheterisation
Being underweight, and not overweight, has the highest mortality, cost, length of stay, and readmission rate for those undergoing cardiac catheterisation, according to an analysis of more than one million patients presented at ESC Congress today.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
Gender gap in death from heart attack reduces particularly in younger women
The gender gap in death from heart attack has reduced over the past two decades particularly in younger women, according to research presented today at ESC Congress.1 The study in over 50 000 patients found that overall in-hospital mortality for heart attack patients was halved during the 20 year period.
The AMIS Plus registry is funded by unrestricted grants from the Swiss Heart Foundation and from Abbott AG, AstraZeneca AG, Bayer (Schweiz) AG, B. Braun Medical AG, Biotronik AG, Cordis-Cardinal Health, Mepha Pharma AG, Merck Sharp & Dohme-Chibret AG, Nov

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 26-Aug-2017
ESC Congress 2017
Women less likely to receive recommended statin doses to prevent cardiovascular events
Women at high risk of cardiovascular events are less likely to receive recommended statin doses for secondary prevention, according to results from the DYSIS study presented today at ESC Congress.
Merck Inc.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 25-Aug-2017
Theoretical Biology and Medical Modeling
Researchers predicted when cholera epidemic in Yemen would peak
Hokkaido University scientists has developed a new mathematical model which accurately forecast that a devastating cholera epidemic in Yemen would peak by early July, the 26th week of 2017 and the cumulative incidence would be the order of 700-800 thousand cases.

Contact: Naoki Namba
81-117-062-185
Hokkaido University

Public Release: 24-Aug-2017
Clinical Infectious Diseases
Rapid diagnostic test helps distinguish between severe and uncomplicated malaria in Africa
Working at a health center in rural Uganda, researchers from the University of North Carolina at Chapel Hill demonstrated for the first time the potential of using a low-cost, routinely available rapid diagnostic test to distinguish between severe and uncomplicated malaria in children.
Harvard Global Health Initiative, Thrasher Research Fund, Standard Diagnostics, Abbott Point of Care

Contact: Morag MacLachlan
morag_maclachlan@med.unc.edu
919-843-5719
University of North Carolina Health Care

Public Release: 24-Aug-2017
Illegal dumping during road construction in Ethiopia affects child mortality
Researchers have shown that living near newly built roads in Ethiopia is associated with higher rates of infant mortality. Proximity to new roads has negative health effects because of toxic waste dumped illegally during the construction phase.

Contact: Mark Byrne
m.byrne@qmul.ac.uk
44-207-882-5378
Queen Mary University of London

Public Release: 24-Aug-2017
IDRI to continue development of inhalable TB drug candidate
IDRI (Infectious Disease Research Institute), on behalf of the Lilly TB Drug Discovery Initiative, announces it has entered into an agreement with Zhejiang Hisun Pharmaceutical Co., Ltd., a China-based leading biopharmaceutical company, to continue development of inhalable CPZEN-45, a tuberculosis (TB) drug candidate that could potentially treat the growing problem of antibiotic-resistant TB.

Contact: Lee Schoentrup
Lee.Schoentrup@idri.org
206-858-6064
Infectious Disease Research Institute

Public Release: 24-Aug-2017
Cell
Leprosy turns the immune system against itself, study finds
Leprosy hijacks our immune system, turning an important repair mechanism into one that causes potentially irreparable damage to our nerve cells, according to new research that uses zebrafish to study the disease. As such, the disease may share common characteristics with conditions such as multiple sclerosis.
National Institutes of Health, Wellcome Trust, AP Giannini Foundation

Contact: Craig Brierley
researchcommunications@admin.cam.ac.uk
44-122-333-2300
University of Cambridge

Public Release: 23-Aug-2017
Viruses
On the other hand, the immune system can also cause cancer
CU Cancer Center study describes how immune response designed to scramble viral DNA can scramble human DNA as well, sometimes in ways that cause cancer.
National Institutes of Health, US Department of Agriculture

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Anschutz Medical Campus

Public Release: 23-Aug-2017
Clinical Microbiology and Infection
Reducing infant mortality in Nigeria
A doctor in Nigeria and a professor at Michigan State University have teamed up to reduce infant mortality in the African nation.

Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University

Showing releases 76-100 out of 1397.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>